Ç×¾ÏÁ¦ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Anticancer Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1631434
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 274 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁÖ¿ä ÀλçÀÌÆ®

Ç×¾ÏÁ¦ ½ÃÀå - º¸°í¼­ ¹üÀ§

Ç×¾ÏÁ¦´Â À¯¹æ¾Ï, Æó¾Ï, ´ëÀå¾Ï µî ´Ù¾çÇÑ Á¾·ùÀÇ ¾Ï Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌµé ¾àÁ¦´Â ÁÖ·Î ¾Ï¼¼Æ÷ÀÇ »ç¸ê ¹× Áõ½Ä ¾ïÁ¦¿¡ »ç¿ëµÇ¸ç, È­Çпä¹ý, ¸é¿ª¿ä¹ý, Ç¥Àû Ä¡·áÁ¦, È£¸£¸ó¿ä¹ýÀ¸·Î ºÐ·ùµË´Ï´Ù. ½ÃÀåÀº ¸ÂÃãÀÇ·á¿Í ¸é¿ªÁ¾¾çÇп¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ º´¿ø, Áø·á¼Ò, Á¾¾ç¼¾Å͸¦ ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀº ¾Ï ¹ßº´·üÀÇ Áõ°¡, ÀǾàǰ °³¹ßÀÇ Áøº¸, ¼¼°è ÀÇ·áºñ Áõ°¡ÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°è Ç×¾ÏÁ¦ ½ÃÀåÀº Àü ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡, °í·ÉÈ­·Î ÀÎÇÑ ¾Ï °ü·Ã Áúȯ ¹ßº´·ü Áõ°¡ µî ¿©·¯ °¡Áö ÁÖ¿ä ¿äÀο¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. °³Àκ° À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸ÂÃá Ä¡·á¸¦ À§ÇÑ Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ Ç×¾ÏÁ¦ÀÇ È¿´ÉÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸é¿ª¿ä¹ý ¹× Ç¥Àû Ä¡·áÁ¦¸¦ Áß½ÉÀ¸·Î ÇÑ »õ·Î¿î Ç×¾ÏÁ¦ ÆÄÀÌÇÁ¶óÀÎÀÇ È®Àåµµ ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, CAR-T Ä¡·áÁ¦, PD-1 ¾ïÁ¦Á¦ µî ÃÖ÷´Ü ¾à¹°ÀÇ ½ÂÀεµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶óÀÇ Áõ°¡, ¿¬±¸°³¹ß ÅõÀÚ È®´ë, ¹ÙÀÌ¿À Á¦¾à±â¾÷°ú ÇаèÀÇ °øµ¿¿¬±¸´Â ½ÃÀåÀÇ ¹Ì·¡¼ºÀ» ´õ¿í ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ

À¯¸ÁÇÑ ¼ºÀå¼¼¿¡µµ ºÒ±¸Çϰí, Ç×¾ÏÁ¦ ½ÃÀåÀº ½ÅÈï±¹ ȯÀÚµéÀÇ Á¢±Ù¼ºÀ» Á¦ÇÑÇÒ ¼ö ÀÖ´Â ³ôÀº Ç×¾ÏÁ¦ ºñ¿ë°ú °°Àº µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î Ç×¾ÏÁ¦ ½ÂÀο¡ ´ëÇÑ ±ÔÁ¦ À庮ÀÌ Á¸ÀçÇϰí, ÀÓ»ó½ÃÇè¿¡ ¼Ò¿äµÇ´Â ±â°£ÀÌ ±æ¾î ½ÃÀå ÁøÀÔ¿¡ Å« °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÁ¤ Ä¡·áÁ¦ÀÇ ºÎÀÛ¿ë °¡´É¼º ¹× Ç×¾ÏÁ¦ ³»¼º À§ÇèÀº Ç×¾ÏÁ¦ÀÇ È¿°ú¸¦ Á¦ÇÑÇϰí ȯÀÚ °á°ú ¹× Ä¡·á ¼øÀÀµµ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ

Ç×¾ÏÁ¦ ½ÃÀåÀº ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿Í À¯ÀüüÇÐÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î Å« ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. üũÆ÷ÀÎÆ® ¾ïÁ¦Á¦¿Í °°Àº ¸é¿ª¿ä¹ýÀº ±âÁ¸ È­Çпä¹ý¿¡ ºñÇØ ºÎÀÛ¿ëÀÌ Àû°í Áö¼ÓÀûÀÎ È¿°ú¸¦ ±â´ëÇÒ ¼ö ÀÖ¾î ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ƯÁ¤ ºÐÀÚ Ç¥Àû¿¡ ÃÊÁ¡À» ¸ÂÃá Ç¥Àû Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå ÀáÀç·ÂÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÀÇ·á¿Í º´¿ë¿ä¹ýÀº Ç×¾ÏÁ¦ ºÐ¾ßÀÇ ÁÖ¿ä Æ®·»µå°¡ µÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ȯÀڵ鿡°Ô º¸´Ù °³ÀÎÈ­µÇ°í È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÒ °ÍÀÔ´Ï´Ù. Àü·«Àû Á¦ÈÞ, M&A, Ç×¾ÏÁ¦ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ´Â »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå¿¡¼­ÀÇ ¸®´õ½ÊÀ» À¯ÁöÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù.

¼¼°è Ç×¾ÏÁ¦ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ¼Ò°³

Á¦3Àå Ç×¾ÏÁ¦ ½ÃÀå ±âȸ ºÐ¼®

Á¦4Àå ½ÃÀå ¹è°æ

Á¦5Àå °Å½Ã°æÁ¦ °¡Á¤

Á¦6Àå ¼¼°è °æÁ¦ Àü¸Á

Á¦7Àå ÁÖ¿ä ³»¿ë

Á¦8Àå ºÏ¹ÌÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â)

Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â)

Á¦10Àå À¯·´ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â)

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â)

Á¦12Àå ÀϺ»ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â)

Á¦13Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â)

Á¦14Àå ¿¹Ãø¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ

Á¦15Àå ¿¹Ãø °¡Á¤

Á¦16Àå °æÀï ºÐ¼®

Á¦17Àå ¼¼°èÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â) : Áö¿ªº°

Á¦18Àå ¼¼°èÀÇ Ç×¾ÏÁ¦ ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â) : ¾à¹° Á¾·ùº°

Á¦19Àå ¼¼°èÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â) : ÀûÀÀÁõº°

Á¦20Àå ¼¼°èÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â) : À¯Åë ä³Îº°

Á¦21Àå ¼¼°èÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼®(2019-2024³â)°ú ¿¹Ãø(2025-2032³â)

Á¦22Àå Á¶»ç ¹æ¹ý

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the worldwide market for anticancer drugs. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global anticancer drugs market from 2025 to 2032.

Key Insights:

Anticancer Drugs Market - Report Scope:

Anticancer drugs are widely used in the treatment of various types of cancer, including breast cancer, lung cancer, and colorectal cancer, among others. These drugs are primarily used to kill or inhibit the growth of cancer cells and are categorized into chemotherapy, immunotherapy, targeted therapy, and hormone therapy. The market caters to hospitals, clinics, and oncology centers, with a growing focus on personalized medicine and immuno-oncology. Market growth is driven by the rising incidence of cancer, advancements in drug development, and increasing healthcare spending worldwide.

Market Growth Drivers:

The global anticancer drugs market is propelled by several key factors, including the rising prevalence of cancer globally, with an aging population being particularly vulnerable to cancer-related diseases. The increasing focus on precision medicine, which tailors treatment to individual genetic profiles, is enhancing the efficacy of anticancer drugs. Additionally, the expanding pipeline of novel anticancer agents, particularly in immunotherapy and targeted therapies, is driving market expansion. The approval of cutting-edge drugs such as CAR-T therapies and PD-1 inhibitors is also boosting growth. Increasing healthcare infrastructure, growing investments in research and development, and collaborations between biopharmaceutical companies and academic institutions are expected to further enhance market prospects.

Market Restraints:

Despite promising growth, the anticancer drugs market faces challenges, including the high cost of novel cancer treatments, which can limit access for patients in emerging economies. Regulatory hurdles for the approval of new anticancer drugs and the long timelines required for clinical trials pose significant obstacles to market entry. Furthermore, the potential for adverse side effects of certain treatments and the risk of resistance to cancer drugs can limit their effectiveness, affecting patient outcomes and treatment adherence.

Market Opportunities:

The anticancer drugs market presents significant opportunities driven by ongoing advancements in biotechnology and genomics. Immunotherapies, such as checkpoint inhibitors, are gaining popularity due to their potential to provide durable responses with fewer side effects compared to traditional chemotherapy. The increasing demand for targeted therapies, which focus on specific molecular targets, is expanding market potential. Personalized medicine and combination therapies are expected to become key trends in the anticancer drugs space, offering patients more tailored and effective treatment options. Strategic collaborations, mergers and acquisitions, and investments in cancer drug research are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading players in the global anticancer drugs market, such as Roche Holding AG, Bristol-Myers Squibb Company, Novartis AG, and Merck & Co., Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop next-generation drugs, including immunotherapies and targeted therapies, catering to the diverse needs of cancer patients. Collaborations with research institutions, healthcare providers, and government agencies are facilitating faster drug development and market access. Additionally, key players are focusing on expanding their global presence and enhancing drug affordability through pricing strategies and partnerships with generic drug manufacturers.

Key Companies Profiled:

Anticancer Drugs Market Research Segmentation:

By Drug Type:

By Application:

By End-User:

By Region:

Table of Contents

1. Executive Summary

2. Market Introduction

3. Anti-Cancer Drugs Market Opportunity Analysis

4. Market Background

5. Macroeconomic Assumptions

6. Global Economic Outlook

7. Key Inclusions

8. North America Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032

9. Latin America Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032

10. Europe Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032

11. Asia Pacific Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032

12. Japan Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032

13. Middle East & Africa Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis

17. Global Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Region

18. Global Anti-Cancer Drugs Analysis 2019 - 2024 and Forecast 2025 - 2032, By Drug Class

19. Global Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Indications

20. Global Anti-cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032, By Distribution Channels

21. Global Anti-Cancer Drugs Market Analysis 2019 - 2024 and Forecast 2025 - 2032

22. Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â